Date | Title |
Dec 18, 2014
|
Forms 8937 for Preferred Shares 671.5 KB
|
Dec 18, 2014
|
Forms 8937 for Common Shares 646.6 KB
|
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investors:
Michael Tung, M.D.
Corporate Strategy / Investor Relations
1.415.978.1434
mtung@fibrogen.com
Media Inquiries:
Jennifer Harrington
+1.610.574.9196
jennifer.harrington@gcihealth.com